Glycosyl Phosphatidylinositol-Anchored C34 Peptide Derived From Human Immunodeficiency Virus Type 1 Gp41 Is a Potent Entry Inhibitor.
about
Biomedical applications of glycosylphosphatidylinositol-anchored proteinsPromoting Global Health - Prevention and Treatment of Substance Abuse and HIV in Asia.Divergent Requirement of Fc-Fcγ Receptor Interactions for In Vivo Protection against Influenza Viruses by Two Pan-H5 Hemagglutinin Antibodies.Glycosyl-phosphatidylinositol-Anchored Anti-HIV Env Single Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.
P2860
Glycosyl Phosphatidylinositol-Anchored C34 Peptide Derived From Human Immunodeficiency Virus Type 1 Gp41 Is a Potent Entry Inhibitor.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Glycosyl Phosphatidylinositol- ...... 1 Is a Potent Entry Inhibitor.
@en
type
label
Glycosyl Phosphatidylinositol- ...... 1 Is a Potent Entry Inhibitor.
@en
prefLabel
Glycosyl Phosphatidylinositol- ...... 1 Is a Potent Entry Inhibitor.
@en
P2093
P2860
P1476
Glycosyl Phosphatidylinositol- ...... 41 Is a Potent Entry Inhibitor
@en
P2093
Jason T Kimata
Michael Wen
Qianqian Zhu
P2860
P2888
P304
P356
10.1007/S11481-016-9681-X
P50
P577
2016-05-07T00:00:00Z